PCASPEN Stock Latest News
Private CompaniesAspen Neuroscience Highlights Nasdaq Milestone and Regenerative Therapy Focus11h agoASPEN
Private CompaniesAspen Neuroscience Begins Trading on Nasdaq Under Ticker ASPE1w agoASPEN
Private CompaniesAspen Neuroscience Marks IPO Debut With Nasdaq Tower Feature1w agoASPEN
Private CompaniesAspen Neuroscience Highlights Preclinical Milestone in Parkinson’s Cell Therapy Program1M agoASPEN
Private CompaniesAspen Neuroscience Highlights Parkinson’s Focus and Advocacy Alignment1M agoASPENPrivate CompaniesPatient-Centric Focus Underscores Aspen Neuroscience’s Parkinson’s Therapy Strategy2M agoASPEN
Private CompaniesAspen Neuroscience Showcases Parkinson’s Cell Therapy Research at Oxford Conference2M agoASPEN
Private CompaniesAspen Neuroscience Highlights Engagement in Parkinson’s Disease Community2M agoASPEN
Private CompaniesCommunity Education Initiative Underscores Aspen Neuroscience’s CSR Focus3M agoASPEN
Private CompaniesAspen Neuroscience Gains Key FDA Designation for Parkinson’s Cell Therapy3M agoASPENPrivate CompaniesAspen Neuroscience Highlights Role in Regenerative Medicine and ISSCR Sponsorship4M agoASPEN
Private CompaniesAspen Neuroscience Bolsters Legal Leadership Amid Advancing Clinical Programs5M agoASPEN
Private CompaniesAspen Neuroscience Deepens Parkinson’s Focus with World Congress Engagement5M agoASPEN
Private CompaniesAspen Neuroscience Highlights Engagement at World Parkinson Congress5M agoASPEN
Private CompaniesAspen Neuroscience Highlights Engagement at World Parkinson Congress5M agoASPEN
Private CompaniesAspen Neuroscience Inc – Weekly Recap5M agoASPENPrivate CompaniesAspen Neuroscience Highlights Engagement Strategy at World Parkinson Congress5M agoASPEN



